NKNazik Doğramaci Köprülü

Nazik Doğramaci Köprülü

*This is an algorithmically generated author record based on publicly available information.

Nazik Doğramaci Köprülü has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Relationship of ABO Blood Groups to SARS-COV-2 Infection Causing COVID-19 Disease

    by Özlem Ki̇rİşCi̇, Suat Özlük, Ümmühan Su Topalca, Nazik Doğramaci Köprülü

    Objective: We aimed to investigate whether there is a predisposition to COVID-19 with ABO and Rh blood group systems. Methods: The clinical data of 455 patients with COVID-19 seen between April 17, 2020, and June 30, 2020, at the Necip Fazıl City Hospital were retrospectively analyzed studied. The differences in the ABO blood group distribution between COVID-19 patients and the control group (7844 cases) were analyzed. Results: The percentage of patients with type O blood in the COVID-19 group was significantly lower than that in the control group (29.7% vs. 35.6%, p = 0.009). The percentage of patients with type A and B blood in the COVID-19 set was higher than in the control group however, there were no significant differences, respectively (44.4% vs. 40.8%, 19.3% vs.16.6%, p = 0.134, p=0.123). Patients with blood group O had a lower risk of COVID-19 than A, B blood group patients (respectively; OR = 0.732, OR=0.594, p = 0.023, p=0.001). The risk of COVID-19 was higher for patients with blood groups A and B than with a blood group 0 (OR = 1.365, OR= 1.684, p = 0.023, p=0.001). The Rh blood group phenotype was not statistically significant in determining a patient’s vulnerability. Conclusion: The results of the present study suggest that while the blood group 0 had a low risk and decreased risk for infection with SARS-CoV-2, whereas blood group A and B were associated related with an increased risk, indicating that certain specific ABO blood groups were connected correlated with SARS-CoV-2 susceptibility.